MedTrace Logo

Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard

NCT02801162 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-11-18

No results posted yet for this study

Summary

Evaluate the precision and accuracy of the Proxima 3® System by obtaining quantitative clinical data at various time points. Compare the methods associated with obtaining blood gas results using the Proxima 3® System device versus a conventional ABG analyse. The aim of the investigator is to evaluate the precision and accuracy of the Proxima 3® ABG system parameters (pH, pCO2 pO2, hematocrit and potassium) in clinical practices with rapid changing context.

Conditions

Interventions

DEVICE

conventional ABG analyser

pO2 mmHg, pH, pCO2 mmHg, Base excess, Hct %

DEVICE

Proxima 3®

pO2 mmHg, pH, pCO2 mmHg, Base excess, Hct %

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Principal Investigators

  • Vincent Umbrain, MD PhD · Universitair Ziekenhuis Brussel

  • Jan Poelaert, MD, PhD · Universitair Ziekenhuis Brussel

  • Manuella Martin, Apr. Biol. · Universitair Ziekenhuis Brussel

  • Christine Sneyers, Nurse · Universitair Ziekenhuis Brussel

  • Gabriel Kotolácsi, MD · Universitair Ziekenhuis Brussel

  • Pierre Matagne, Nurse · Universitair Ziekenhuis Brussel

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-02-28
Completion
2017-04-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02801162 on ClinicalTrials.gov